AGENDA: PRECONFERENCE/DAY I
WEDNESDAY, SEPTEMBER 13, 2017
7:00 am
PRECONFERENCE SYMPOSIUM: TRAINING IN COMPLIANCE AND ETHICS BASICS
(Optional; Separate Registration Required)
8:00 am
Presentations and Q&A
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/ahmed_100.jpg)
Vice President, Regional Compliance Officer, Asia and JPAC, Sanofi Group, Singapore
Masood started his career as finance professional with Beecham. He had held positions of CFO in Upjohn, Pharmacia, GSK & vice President Operations Pfizer before embarking on his role as Regional Compliance Officer with Schering-Plough.
Masood had significantly contributed in several merger and integration activities of giant pharmaceutical organizations which provided him unique opportunities of managing people, strategies and processes integration and shaping the corporate culture.
Masood has been intimately involved in the evolution of Pharmaceuticals industry’s compliance environment in challenging markets in Asia.
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/burtmanis_100.jpg)
Regional Compliance Director, Japan / Asia Pacific, Shire, Singapore
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/lee_100.jpg)
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore
He started his career as a solicitor in a leading Singapore law firm, working mainly on corporate matters and cross border commercial transactions, and after thereafter as legal counsel with increasing scope and responsibilities in companies such as Royal Dutch Shell and Halliburton. Gareth has been in legal leadership positions for the last 12 years in the healthcare industry, including Baxter Healthcare, Allergan and now Cardinal Health.
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/tee_100.jpg)
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics; Former Compliance Director, Asia, Abbott Laboratories Pte. Ltd.; Former Associate Director, Compliance (APAC), Allergan, Singapore
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/korenchuk_100.jpg)
Partner, Arnold & Porter LLP, Washington, DC, USA (Moderator)
Since 2001, Mr. Korenchuk has been included in The Best Lawyers in America. He has developed, led, and implemented “hands-on” educational and healthcare programs that provide pharmaceuticals and healthcare services, teachers, school supplies, library resources, and computers to indigenous communities in South America for the past 12 years.
12:00 pm
Preconference Adjournment/Lunch on your Own
DAY I OPENING PLENARY SESSION
(With Simultaneous Chinese/English/Chinese Translation)
1:00 pm
Co-Chair Welcome and Introduction
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/ahmed_100.jpg)
Vice President, Regional Compliance Officer Asia and JPAC, Sanofi Group, Singapore (Co-chair)
Masood started his career as finance professional with Beecham. He had held positions of CFO in Upjohn, Pharmacia, GSK & vice President Operations Pfizer before embarking on his role as Regional Compliance Officer with Schering-Plough.
Masood had significantly contributed in several merger and integration activities of giant pharmaceutical organizations which provided him unique opportunities of managing people, strategies and processes integration and shaping the corporate culture.
Masood has been intimately involved in the evolution of Pharmaceuticals industry’s compliance environment in challenging markets in Asia.
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/burtmanis_100.jpg)
Regional Compliance Director, Japan/Asia Pacific, Shire, Singapore (Co-chair)
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/lee_100.jpg)
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health; Former General Counsel and Head of Compliance, Asia Pacific, Allergan, Singapore (Co-chair)
He started his career as a solicitor in a leading Singapore law firm, working mainly on corporate matters and cross border commercial transactions, and after thereafter as legal counsel with increasing scope and responsibilities in companies such as Royal Dutch Shell and Halliburton. Gareth has been in legal leadership positions for the last 12 years in the healthcare industry, including Baxter Healthcare, Allergan and now Cardinal Health.
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/quindimil_100.jpg)
APAC Ethics and Compliance Lead, UCB Pharma; Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China (Co-chair)
Maru, the former Executive Director, Regional Compliance Officer, Asia for Merck Sharp & Dohme, Asia Ltd., led regional Compliance groups, comprising 26 professional staff in 20 Asia Pacific countries (10,000 employees) for 8 years.
Throughout a career that has spanned 27 years, Maru has applied her background in pharmaceutical and pharmacological research into the commercial pharmaceutical sector where she led the development, launch and market growth of several new products across a diverse range of geographic sectors.
Maru has led APEC Pharmaceutical sector meetings for the implementation of Pharmaceutical codes of conduct and active contributor in AP Compliance Network.
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/tee_100.jpg)
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics; Former Compliance Director, Asia, Abbott Laboratories Pte. Ltd.; Former Associate Director, Compliance (APAC), Allergan, Singapore (Co-chair)
1:30 pm
R&D-based Pharmaceutical Association Committee (RDPAC) Pharmaceutical Enterprise Ethical Business Practice and Declaration for Pharmaceutical Innovation
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/dethick_100.jpg)
Managing Director, R&D-based Pharmaceutical Association Committee (RDPAC ); Former Executive Director, China-Britain Business Council; Former Executive Director, British Chamber of Commerce in China; Former Chairman of the Consortium, EU SME Centre, China, Beijing, China
2:00 pm
AdvaMed’s Code of Ethics on Interactions with Health Care Professionals in China (“AdvaMed China Code”)
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/chew_100.jpg)
Head, Ethics and Compliances, Medtronic Greater China, Former Senior Manager Commercial Assurance Greater China/Central Asia, Becton Dickinson, Shanghai, China
2:45 pm
The Continued Evolution of Compliance as a Profession: Background, Training, Roles and Responsibilities
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/burtmanis_100.jpg)
Regional Compliance Director, Japan / Asia Pacific, Shire, Former Healthcare CO, Asia Pacific Medical Sciences, Johnson & Johnson, Former Associate GC, Alcon Russia, Former Asia Pacific, Country CO, Novartis SG, Singapore
3:30 pm
Break
4:00 pm
Keynote
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/gisserot_100.jpg)
Senior Vice President and Head of Pharmaceuticals, Asia Pacific, GSK; Former Senior Vice President and General Manager of Pharmaceuticals and Vaccines, GSK (China); Former President, Leem, Singapore
Hervé joined GSK in June 2008 as SVP and General Manager of GSK France from Sanofi-Aventis where he was General Manager for Commercial Operations in Germany. Before that, he was with the Sanofi-Aventis Group in the United States where he was Global Franchise Head in Global Marketing and a Business Unit Head in the US local subsidiary.
Previously, Hervé worked with the Fournier Group holding a variety of positions both in France and abroad. Hervé was Chairman of the LEEM (Association of the French Drug Companies) after holding a position on the Board since 2008. He was also President of the LIR (Laboratoires Internationaux de Recherche), a French Think Tank consisting of 16 International Research-Based Pharmaceutical Companies”.
4:45 pm
Global Chief Compliance Officer Roundtable
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/ahmed_100.jpg)
Vice President, Regional Compliance Officer, Asia and JPAC, Sanofi Group, Singapore
Masood started his career as finance professional with Beecham. He had held positions of CFO in Upjohn, Pharmacia, GSK & vice President Operations Pfizer before embarking on his role as Regional Compliance Officer with Schering-Plough.
Masood had significantly contributed in several merger and integration activities of giant pharmaceutical organizations which provided him unique opportunities of managing people, strategies and processes integration and shaping the corporate culture.
Masood has been intimately involved in the evolution of Pharmaceuticals industry’s compliance environment in challenging markets in Asia.
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/kurlander_100.jpg)
Vice President, Health Care Compliance, Privacy, FCPA, Ortho Clinical Diagnostics; Former Finance Director, Tax and Commercial Compliance, Ethicon, A Johnson & Johnson Company, New York, NY, USA
Mr. Kurlander has served on several AdvaMed committees. Mr. Kurlander is also a Certified Public Accountant, Certified Managerial Accountant, and a Certified Managed Care Coordinator.
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/orrico_100.jpg)
Senior Vice President, Chief Compliance and Risk Officer, Shire; Vice President and Associate General Counsel, Compliance, Baxalta Incorporated; Former Senior Counsel, Baxter International Inc., Chicago, IL, USA
![](https://www.asianpharmacongress.com/wp-content/themes/ipc/faculty/acosta_100.jpg)
Americas Vice Chair, Risk Management, EY; Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France (Moderator)
In 2014, Ted was named Vice Chair of Risk for EY’s Americas and US firms and appointed to their management boards. He leads the Risk Management organization, which covers internal risk assessments, compliance, ethics, privacy and independence, as well enterprise risk management, and client and engagement acceptance, among others. Ted also chairs EY Americas’ ethics board and sits on EY’s Global Risk Management Executive Committee and the Global Practice Group.
6:00 pm
Adjournment